Search

Your search keyword '"Garcia, Blanca E."' showing total 7 results
Start Over Author "Garcia, Blanca E." Search Limiters Full Text Publication Year Range Last 10 years
7 results on '"Garcia, Blanca E."'

4. Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry

Author

Kraft, Magdalena, Knop, Macarena Pia, Renaudin, Jean-Marie, Scherer Hofmeier, Kathrin, Pföhler, Claudia, Bilò, Maria Beatrice, Lang, Roland, Treudler, Regina, Wagner, Nicola, Spindler, Thomas, Hourihane, Jonathan O'B, Maris, Ioana, Koehli, Alice, Bauer, Andrea, Lange, Lars, Müller, Sabine, Papadopoulos, Nikolaos G, Wedi, Bettina, Moeser, Anne, Ensina, Luis F, Fernandez-Rivas, Montserrat, Cichocka-Jarosz, Ewa, Christoff, George, Garcia, Blanca E, Poziomkowska-Gęsicka, Iwona, Cardona, Victoria, Mustakov, Tihomir B, Rabe, Uta, Mahler, Vera, Grabenhenrich, Linus, et al, and University of Zurich

Subjects
2403 Immunology, 10036 Medical Clinic, 2723 Immunology and Allergy, 610 Medicine & health
Published
2020

5. Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry

Author

Kraft, Magdalena; https://orcid.org/0000-0002-2770-9947, Knop, Macarena Pia, Renaudin, Jean-Marie, Scherer Hofmeier, Kathrin, Pföhler, Claudia, Bilò, Maria Beatrice, Lang, Roland, Treudler, Regina, Wagner, Nicola, Spindler, Thomas, Hourihane, Jonathan O'B, Maris, Ioana, Koehli, Alice, Bauer, Andrea, Lange, Lars; https://orcid.org/0000-0003-1104-5848, Müller, Sabine, Papadopoulos, Nikolaos G, Wedi, Bettina; https://orcid.org/0000-0002-9868-6308, Moeser, Anne, Ensina, Luis F, Fernandez-Rivas, Montserrat, Cichocka-Jarosz, Ewa, Christoff, George, Garcia, Blanca E, Poziomkowska-Gęsicka, Iwona, Cardona, Victoria; https://orcid.org/0000-0003-2197-9767, Mustakov, Tihomir B, Rabe, Uta, Mahler, Vera, Grabenhenrich, Linus, et al, Kraft, Magdalena; https://orcid.org/0000-0002-2770-9947, Knop, Macarena Pia, Renaudin, Jean-Marie, Scherer Hofmeier, Kathrin, Pföhler, Claudia, Bilò, Maria Beatrice, Lang, Roland, Treudler, Regina, Wagner, Nicola, Spindler, Thomas, Hourihane, Jonathan O'B, Maris, Ioana, Koehli, Alice, Bauer, Andrea, Lange, Lars; https://orcid.org/0000-0003-1104-5848, Müller, Sabine, Papadopoulos, Nikolaos G, Wedi, Bettina; https://orcid.org/0000-0002-9868-6308, Moeser, Anne, Ensina, Luis F, Fernandez-Rivas, Montserrat, Cichocka-Jarosz, Ewa, Christoff, George, Garcia, Blanca E, Poziomkowska-Gęsicka, Iwona, Cardona, Victoria; https://orcid.org/0000-0003-2197-9767, Mustakov, Tihomir B, Rabe, Uta, Mahler, Vera, Grabenhenrich, Linus, and et al

Abstract

BACKGROUND Patients with a history of anaphylaxis are at risk of future anaphylactic reactions. Thus, secondary prevention measures are recommended for these patients to prevent or attenuate the next reaction. METHODS Data from the Anaphylaxis Registry were analyzed to identify secondary prevention measures offered to patients who experienced anaphylaxis. Our analysis included 7788 cases from 10 European countries and Brazil. RESULTS The secondary prevention measures offered varied across the elicitors. A remarkable discrepancy was observed between prevention measures offered in specialized allergy centers (84% of patients were prescribed adrenaline autoinjectors following EAACI guidelines) and outside the centers: Here, EAACI guideline adherence was only 37%. In the multivariate analysis, the elicitor of the reaction, age of the patient, mastocytosis as comorbidity, severity of the reaction, and reimbursement/availability of the autoinjector influence physician's decision to prescribe one. CONCLUSIONS Based on the low implementation of guidelines concerning secondary prevention measures outside of specialized allergy centers, our findings highlight the importance of these specialized centers and the requirement of better education for primary healthcare and emergency physicians.

Published
2020

6. Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry

Author

Kraft, Magdalena, Knop, Macarena Pia, Renaudin, Jean-Marie, Scherer Hofmeier, Kathrin, Pföhler, Claudia, Bilò, Maria Beatrice, Lang, Roland, Treudler, Regina, Wagner, Nicola, Spindler, Thomas, O'B Hourihane, Jonathan, Maris, Ioana, Koehli, Alice, Bauer, Andrea, Lange, Lars, Müller, Sabine, Papadopoulos, Nikolaos G., Wedi, Bettina, Moeser, Anne, Ensina, Luis F., Fernandez-Rivas, Montserrat, Cichocka-Jarosz, Ewa, Christoff, George, Garcia, Blanca E., Poziomkowska-Gęsicka, Iwona, Cardona, Victoria, Mustakov, Tihomir B., Rabe, Uta, Mahler, Vera, Grabenhenrich, Linus, Dölle-Bierke, Sabine, Worm, Margitta, and The Network for Online Registration of Anaphylaxis (NORA)

Subjects
epinephrine autoinjector, adrenaline autoinjector, anaphylaxis, ddc:610, 610 Medizin und Gesundheit, secondary prevention, anaphylactic reaction
Abstract

Background Patients with a history of anaphylaxis are at risk of future anaphylactic reactions. Thus, secondary prevention measures are recommended for these patients to prevent or attenuate the next reaction. Methods Data from the Anaphylaxis Registry were analyzed to identify secondary prevention measures offered to patients who experienced anaphylaxis. Our analysis included 7788 cases from 10 European countries and Brazil. Results The secondary prevention measures offered varied across the elicitors. A remarkable discrepancy was observed between prevention measures offered in specialized allergy centers (84% of patients were prescribed adrenaline autoinjectors following EAACI guidelines) and outside the centers: Here, EAACI guideline adherence was only 37%. In the multivariate analysis, the elicitor of the reaction, age of the patient, mastocytosis as comorbidity, severity of the reaction, and reimbursement/availability of the autoinjector influence physician's decision to prescribe one. Conclusions Based on the low implementation of guidelines concerning secondary prevention measures outside of specialized allergy centers, our findings highlight the importance of these specialized centers and the requirement of better education for primary healthcare and emergency physicians.

Published
2019

7. Correction: Garcia et al. Primary Model for Biomass Growth Prediction in Batch Fermentation. Symmetry 2021, 13 , 1468.

Author

Garcia, Blanca E., Rodriguez, Emmanuel, Salazar, Yolocuauhtli, Valle, Paul A., Flores-Gallegos, Adriana C., Rutiaga-Quiñones, O. Miriam, and Rodriguez-Herrera, Raul

Subjects
*BIOMASS, *FERMENTATION, *SYMMETRY, *BIOCHEMICAL engineering
Abstract

SP 2 sp Postgraduate Program in Engineering, Tecnológico Nacional de México/IT Durango, Blvd. Felipe Pescador 1830 Ote., Durango 34080, Mexico; 10040780@itdurango.edu.mx SP 3 sp BioMath Research Group, Postgraduate Program in Engineering Sciences, Tecnológico Nacional de México/IT Tijuana, Blvd. Alberto Limón Padilla s/n, Tijuana 22454, Mexico SP 4 sp Department of Chemical and Biochemical Engineering, Tecnológico Nacional de México/IT Durango, Blvd. Felipe Pescador 1830 Ote., Durango 34080, Mexico; omrutiaga@itdurango.edu.mx * Correspondence: ysalazar@itdurango.edu.mx (Y.S.); Paul.valle@tectijuana.edu.mx (P.A.V.) Author Contributions Conceptualization, Y.S., O.M.R.-Q. and R.R.-H.; methodology, Y.S. and E.R.; software, P.A.V.; validation, Y.S., B.E.G. and P.A.V.; formal analysis, Y.S. and P.A.V.; investigation, E.R. and A.C.F.-G.; resources, B.E.G.; data curation, B.E.G.; writing - original draft preparation, Y.S. and E.R.; writing - review and editing, P.A.V.; visualization, Y.S. and P.A.V.; supervision, Y.S. and P.A.V.; project administration, Y.S. All authors have read and agreed to the published version of the manuscript. Adriana C. Flores-Gallegos, O. Miriam Rutiaga-Quiñones and Raul Rodriguez-Herrera were not included as authors in the original publication. [Extracted from the article]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results